The Latest
-
Medtronic to cut 81 employees at California diabetes site
As Medtronic prepares to spin out its diabetes business, a spokesperson said the company is considering the structure, capabilities and scale needed to succeed.
-
Sponsored by Infineon
Transforming epilepsy care: How innovative implantable neurotechnology offers new hope
Minimally invasive brain stimulation may be the new frontline treatment for drug-resistant patients.
-
Senseonics launches automated insulin dosing system with 1-year CGM
The company has integrated its Eversense 365 implant with Sequel Med Tech’s insulin delivery system to automate the management of Type 1 diabetes.
-
Apple Watch’s hypertension feature may miss some cases, researchers find
The absence of an alert provides limited reassurance, particularly for older adults or people with an elevated risk of high blood pressure, according to the study’s authors.
-
FDA issues early alert on Trividia glucometer issue linked to 114 injuries
Users may receive an error code either due to a test strip error or a very high blood glucose event, Trividia Health said.
-
Medtronic nets FDA clearance for robotic spine system
Called Stealth AXiS, the surgical system builds on Medtronic’s Mazor robotic platform, as the medical device maker takes market share in the $15 billion cranial and spinal technologies sector.
-
Federal judge strikes down FTC rule expanding premerger reporting requirements
The regulation required firms to provide more details ahead of mergers, likely chilling dealmaking. The Federal Trade Commission could appeal the ruling.
-
Danaher to buy Masimo for $9.9B to boost diagnostics portfolio
Masimo’s board considered other potential partners before determining Danaher was an “ideal fit,” executives at the patient monitoring company said.